• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于分子动力学模拟的水在人 N-甲酰肽受体 1(FPR1)激活机制中的作用。

The role of water in activation mechanism of human N-formyl peptide receptor 1 (FPR1) based on molecular dynamics simulations.

机构信息

International Institute of Molecular and Cell Biology, Warsaw, Poland.

出版信息

PLoS One. 2012;7(11):e47114. doi: 10.1371/journal.pone.0047114. Epub 2012 Nov 26.

DOI:10.1371/journal.pone.0047114
PMID:23189124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3506623/
Abstract

The Formyl Peptide Receptor 1 (FPR1) is an important chemotaxis receptor involved in various aspects of host defense and inflammatory processes. We constructed a model of FPR1 using as a novel template the chemokine receptor CXCR4 from the same branch of the phylogenetic tree of G-protein-coupled receptors. The previously employed template of rhodopsin contained a bulge at the extracellular part of TM2 which directly influenced binding of ligands. We also conducted molecular dynamics (MD) simulations of FPR1 in the apo form as well as in a form complexed with the agonist fMLF and the antagonist tBocMLF in the model membrane. During all MD simulation of the fMLF-FPR1 complex a water molecule transiently bridged the hydrogen bond between W254(6.48) and N108(3.35) in the middle of the receptor. We also observed a change in the cytoplasmic part of FPR1 of a rotamer of the Y301(7.53) residue (tyrosine rotamer switch). This effect facilitated movement of more water molecules toward the receptor center. Such rotamer of Y301(7.53) was not observed in any crystal structures of GPCRs which can suggest that this state is temporarily formed to pass the water molecules during the activation process. The presence of a distance between agonist and residues R201(5.38) and R205(5.42) on helix TM5 may suggest that the activation of FPR1 is similar to the activation of β-adrenergic receptors since their agonists are separated from serine residues on helix TM5. The removal of water molecules bridging these interactions in FPR1 can result in shrinking of the binding site during activation similarly to the shrinking observed in β-ARs. The number of GPCR crystal structures with agonists is still scarce so the designing of new ligands with agonistic properties is hampered, therefore homology modeling and docking can provide suitable models. Additionally, the MD simulations can be beneficial to outline the mechanisms of receptor activation and the agonist/antagonist sensing.

摘要

甲酰肽受体 1(FPR1)是一种重要的趋化因子受体,参与宿主防御和炎症过程的各个方面。我们使用趋化因子受体 CXCR4 作为新颖模板构建了 FPR1 模型,该模板来自 G 蛋白偶联受体的系统发育树的同一分支。先前使用的视紫红质模板在 TM2 的细胞外部分有一个凸起,这直接影响了配体的结合。我们还在模型膜中对apo 形式的 FPR1 以及与激动剂 fMLF 和拮抗剂 tBocMLF 复合的 FPR1 进行了分子动力学(MD)模拟。在 fMLF-FPR1 复合物的所有 MD 模拟中,一个水分子暂时桥接了受体中部 W254(6.48)和 N108(3.35)之间的氢键。我们还观察到 FPR1 的细胞质部分的 Y301(7.53)残基(酪氨酸旋转开关)的构象变化。这种效应促进了更多水分子向受体中心的运动。在任何 GPCR 晶体结构中都没有观察到这种 Y301(7.53)的构象,可以表明这种状态是暂时形成的,以便在激活过程中传递水分子。在 TM5 螺旋上,激动剂与残基 R201(5.38)和 R205(5.42)之间存在距离,这可能表明 FPR1 的激活类似于β-肾上腺素能受体的激活,因为它们的激动剂与 TM5 螺旋上的丝氨酸残基分离。在 FPR1 中去除桥接这些相互作用的水分子会导致结合位点在激活过程中收缩,类似于在β-AR 中观察到的收缩。具有激动剂的 GPCR 晶体结构数量仍然很少,因此新的具有激动性的配体的设计受到阻碍,因此同源建模和对接可以提供合适的模型。此外,MD 模拟可以有助于概述受体激活和激动剂/拮抗剂感应的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/6175f56737db/pone.0047114.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/8c3e14c74c90/pone.0047114.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/6c21c5b87c8c/pone.0047114.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/e906cc6859a1/pone.0047114.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/3e0e2009f796/pone.0047114.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/51d58a294bb5/pone.0047114.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/6ae24a8aec7d/pone.0047114.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/0c15cbe7a82e/pone.0047114.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/9a406458a789/pone.0047114.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/3b6b2fd56559/pone.0047114.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/abef94fd45ea/pone.0047114.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/c8afa6a4df81/pone.0047114.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/6175f56737db/pone.0047114.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/8c3e14c74c90/pone.0047114.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/6c21c5b87c8c/pone.0047114.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/e906cc6859a1/pone.0047114.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/3e0e2009f796/pone.0047114.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/51d58a294bb5/pone.0047114.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/6ae24a8aec7d/pone.0047114.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/0c15cbe7a82e/pone.0047114.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/9a406458a789/pone.0047114.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/3b6b2fd56559/pone.0047114.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/abef94fd45ea/pone.0047114.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/c8afa6a4df81/pone.0047114.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fc/3506623/6175f56737db/pone.0047114.g012.jpg

相似文献

1
The role of water in activation mechanism of human N-formyl peptide receptor 1 (FPR1) based on molecular dynamics simulations.基于分子动力学模拟的水在人 N-甲酰肽受体 1(FPR1)激活机制中的作用。
PLoS One. 2012;7(11):e47114. doi: 10.1371/journal.pone.0047114. Epub 2012 Nov 26.
2
Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1.人源甲酰肽受体 1 的 2-(苯并咪唑-2-基硫代)-N-苯基乙酰胺衍生小分子激动剂的分子对接。
J Mol Model. 2012 Jun;18(6):2831-43. doi: 10.1007/s00894-011-1307-x. Epub 2011 Nov 30.
3
Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands.结构决定因素对甲酰肽受体 2 与肽配体的相互作用。
J Biol Chem. 2014 Jan 24;289(4):2295-306. doi: 10.1074/jbc.M113.509216. Epub 2013 Nov 27.
4
Structural basis of ligand binding modes at the human formyl peptide receptor 2.人源甲酰肽受体 2 配体结合模式的结构基础。
Nat Commun. 2020 Mar 5;11(1):1208. doi: 10.1038/s41467-020-15009-1.
5
Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.鉴定人中性粒细胞中 N-甲酰肽受体-1(FPR1)的 C 末端磷酸化位点。
J Biol Chem. 2013 Sep 20;288(38):27042-27058. doi: 10.1074/jbc.M113.484113. Epub 2013 Jul 19.
6
The formyl peptide fMLF primes platelet activation and augments thrombus formation.甲酰肽 fMLF 启动血小板活化并增强血栓形成。
J Thromb Haemost. 2019 Jul;17(7):1120-1133. doi: 10.1111/jth.14466. Epub 2019 May 24.
7
Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity.尿激酶受体衍生肽的结构-功能关系,该肽抑制甲酰肽受体 1 活性。
Sci Rep. 2019 Aug 21;9(1):12169. doi: 10.1038/s41598-019-47900-3.
8
Insights into the Activation Mechanism of the ALX/FPR2 Receptor.深入了解 ALX/FPR2 受体的激活机制。
J Phys Chem Lett. 2020 Nov 5;11(21):8952-8957. doi: 10.1021/acs.jpclett.0c02052. Epub 2020 Oct 8.
9
Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group.配体和受体的结构变化改变了受体对以甲酰甲硫氨酰基起始的中性粒细胞激活肽的偏好。
Biochim Biophys Acta. 2015 Jan;1853(1):192-200. doi: 10.1016/j.bbamcr.2014.10.021. Epub 2014 Oct 30.
10
Stimulation of human formyl peptide receptors by calpain inhibitors: homology modeling of receptors and ligand docking simulation.钙蛋白酶抑制剂对人源甲酰肽受体的刺激:受体同源建模和配体对接模拟。
Arch Biochem Biophys. 2011 Dec 15;516(2):121-7. doi: 10.1016/j.abb.2011.09.017. Epub 2011 Oct 7.

引用本文的文献

1
Structural basis for recognition of N-formyl peptides as pathogen-associated molecular patterns.作为病原体相关分子模式的 N-甲酰肽的识别的结构基础。
Nat Commun. 2022 Sep 5;13(1):5232. doi: 10.1038/s41467-022-32822-y.
2
Drug-induced diabetes type 2: In silico study involving class B GPCRs.药物性 2 型糖尿病:涉及 B 类 GPCR 的计算研究。
PLoS One. 2019 Jan 16;14(1):e0208892. doi: 10.1371/journal.pone.0208892. eCollection 2019.
3
The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.甲酰肽受体:配体的多样性与识别机制

本文引用的文献

1
Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field.使用分子动力学自由能微扰和OPLS力场预测绝对溶剂化自由能
J Chem Theory Comput. 2010 May 11;6(5):1509-19. doi: 10.1021/ct900587b. Epub 2010 Apr 14.
2
All-atom empirical potential for molecular modeling and dynamics studies of proteins.蛋白质分子建模和动力学研究的全原子经验势。
J Phys Chem B. 1998 Apr 30;102(18):3586-616. doi: 10.1021/jp973084f.
3
Structure of the δ-opioid receptor bound to naltrindole.δ-阿片受体与纳曲吲哚结合的结构。
Molecules. 2017 Mar 13;22(3):455. doi: 10.3390/molecules22030455.
4
Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors.分子对接技术在G蛋白偶联受体中的最新进展与应用
Molecules. 2017 Feb 22;22(2):340. doi: 10.3390/molecules22020340.
5
Mechanistic Studies on the Stereoselectivity of the Serotonin 5-HT1A Receptor.关于血清素 5-HT1A 受体立体选择性的机制研究。
Angew Chem Int Ed Engl. 2016 Jul 18;55(30):8661-5. doi: 10.1002/anie.201603766. Epub 2016 May 31.
6
Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.天然化合物及其合成衍生物对人甲酰肽受体1的拮抗作用。
Int Immunopharmacol. 2016 Aug;37:43-58. doi: 10.1016/j.intimp.2015.08.036. Epub 2015 Sep 15.
7
A dynamic view of molecular switch behavior at serotonin receptors: implications for functional selectivity.5-羟色胺受体分子开关行为的动态观点:对功能选择性的影响。
PLoS One. 2014 Oct 14;9(10):e109312. doi: 10.1371/journal.pone.0109312. eCollection 2014.
8
In silico analysis reveals sequential interactions and protein conformational changes during the binding of chemokine CXCL-8 to its receptor CXCR1.计算机模拟分析揭示了趋化因子CXCL-8与其受体CXCR1结合过程中的序列相互作用和蛋白质构象变化。
PLoS One. 2014 Apr 4;9(4):e94178. doi: 10.1371/journal.pone.0094178. eCollection 2014.
9
Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.小分子非肽类甲酰肽受体(FPR)配体的开发及其识别的分子模拟
Curr Med Chem. 2014;21(13):1478-504. doi: 10.2174/0929867321666131218095521.
10
Lipid receptor S1P₁ activation scheme concluded from microsecond all-atom molecular dynamics simulations.从微秒全原子分子动力学模拟中得出的脂质受体 S1P₁激活方案。
PLoS Comput Biol. 2013;9(10):e1003261. doi: 10.1371/journal.pcbi.1003261. Epub 2013 Oct 3.
Nature. 2012 May 16;485(7398):400-4. doi: 10.1038/nature11111.
4
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.阿片肽孤儿受体与肽模拟物复合物的结构。
Nature. 2012 May 16;485(7398):395-9. doi: 10.1038/nature11085.
5
Refinement of protein structure homology models via long, all-atom molecular dynamics simulations.通过长程、全原子分子动力学模拟来完善蛋白质结构同源模型。
Proteins. 2012 Aug;80(8):2071-9. doi: 10.1002/prot.24098. Epub 2012 May 15.
6
Structure of the human κ-opioid receptor in complex with JDTic.人κ-阿片受体与 JDTic 复合物的结构。
Nature. 2012 Mar 21;485(7398):327-32. doi: 10.1038/nature10939.
7
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.μ-阿片受体与吗啡喃拮抗剂结合的晶体结构
Nature. 2012 Mar 21;485(7398):321-6. doi: 10.1038/nature10954.
8
Action of molecular switches in GPCRs--theoretical and experimental studies.分子开关在 G 蛋白偶联受体中的作用——理论与实验研究。
Curr Med Chem. 2012;19(8):1090-109. doi: 10.2174/092986712799320556.
9
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist.人源 M2 毒蕈碱型乙酰胆碱受体与拮抗剂结合的结构。
Nature. 2012 Jan 25;482(7386):547-51. doi: 10.1038/nature10753.
10
Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1.人源甲酰肽受体 1 的 2-(苯并咪唑-2-基硫代)-N-苯基乙酰胺衍生小分子激动剂的分子对接。
J Mol Model. 2012 Jun;18(6):2831-43. doi: 10.1007/s00894-011-1307-x. Epub 2011 Nov 30.